2017
DOI: 10.1038/ng.3838
|View full text |Cite
|
Sign up to set email alerts
|

Spatial heterogeneity in medulloblastoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
99
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
4
1

Relationship

1
9

Authors

Journals

citations
Cited by 119 publications
(110 citation statements)
references
References 52 publications
6
99
0
Order By: Relevance
“…Medulloblastomas are known to exhibit well-characterized intertumoral heterogeneity, as well as geographic, spatial (metastases) and temporal (at recurrence) heterogeneity 1,23,25,[36][37][38][39][40] . Posterior fossa (cerebellar) ependymomas also show marked intertumoral heterogeneity [15][16][17][18][19]27 , while the intertumoral heterogeneity amongst cerebellar pilocytic astrocytomas is not well characterized 26 .…”
Section: Single Cell Heterogeneity In Human Cerebellar Tumorsmentioning
confidence: 99%
“…Medulloblastomas are known to exhibit well-characterized intertumoral heterogeneity, as well as geographic, spatial (metastases) and temporal (at recurrence) heterogeneity 1,23,25,[36][37][38][39][40] . Posterior fossa (cerebellar) ependymomas also show marked intertumoral heterogeneity [15][16][17][18][19]27 , while the intertumoral heterogeneity amongst cerebellar pilocytic astrocytomas is not well characterized 26 .…”
Section: Single Cell Heterogeneity In Human Cerebellar Tumorsmentioning
confidence: 99%
“…Despite very different transcriptomic profiles and associated genomic alterations, no differences in survival exist between these subtypes. More recently, it has been shown that multiple subtypes coexist in different regions 20 and different cells 12 within the same tumour. This interpatient and intratumoural heterogeneity poses a daunting challenge for research programs aimed at developing targeted therapeutic approaches 21 and may explain the failures of such approaches in this disease.…”
Section: Introductionmentioning
confidence: 99%
“…We performed a principal component analysis of the DNA methylation data to elucidate drivers of differences in methylation (258 samples, Figure 3a). Included in the analysis were samples from a second cohort 16,21,22 consisting of 61 multi-sector tumor samples from 11 gliomas, and a control cohort of 64 nonneoplastic brain samples. The first principal component (percentage of variance 75%) separated samples based on IDH-status, as indicated by the IDH-mutant and IDH-wildtype samples from the validation cohort ( Figure 3a).…”
Section: Tumor Purity Is An Important Determinant Of Dna Methylation mentioning
confidence: 99%